Danziten
Payments companies reported to CMS as associated with Danziten. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Danziten, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Danziten
These are the largest totals companies reported as associated with Danziten. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ramalingam Ratnasabapathy | Henderson, NV | Hematology & Oncology | $400.62 |
| Jose Valladares | Victoria, TX | Hematology & Oncology | $200.52 |
| Tryn Smith | Lisle, IL | Physician Assistant | $148.51 |
| Ian Hantman | New Rochelle, NY | Hematology & Oncology | $143.34 |
| Matthew Weist | Lisle, IL | Physician Assistant | $137.86 |
| William Cheung | Bronx, NY | Emergency Medicine | $128.84 |
| Manuel Gonzalez | Sumter, SC | $122.87 | |
| Pete Pow-Anpongkul | Fountain Valley, CA | Hematology & Oncology | $112.39 |
| Paul Lin | Wellington, FL | Hematology & Oncology | $110.33 |
| Hannah Manning | Fountain Valley, CA | Medical | $110.31 |
Prescribed Danziten?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.